WooberlyPharmacy Driver
Business
Only for iPhone
Free · Designed for iPhone. Not verified for macOS.
iPhone
WooberlyPharmacy is a ready-made, 100% customizable on-demand medicine delivery marketplace app that connects customers, delivery partners, and pharmacy stores.
All the involved parties and their activities in the platform are managed and controlled by the admin.
Here’s a glimpse of our exciting features and functionalities!
1. Simple sign-up procedure to get into the app using a phone number.
2. Verify your phone number using Twilio SMS verification.
3. Upload vehicle proof and other legal documents for verification.
4. Manage your availability using an online/offline toggle.
5. Track your earnings made on the platform using the app.
6. Access your past and ongoing orders details.
7. Receive your earnings promptly by giving your bank details.
8. Choose your preferred language, within English, Spanish, French, Indonesian, Japanese, Russian and Arabic.
Ratings & Reviews
- This app has not received enough ratings or reviews to display an overview.
- Bug fixes.
The developer, RadicalStart InfoLab Private Limited, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Provider
- RadicalStart InfoLab Private Limited
- Size
- 68.2 MB
- Category
- Business
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Location
- This app may use your location even when it is not open, which can decrease device battery life.
- Languages
- English
- Age Rating
4+
- 4+
- Contains
Messaging and Chat
User-Generated Content
- Copyright
- ©WooberlyPharmacy 2025
